Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bioavailability and Pharmaco-therapeutic Potential of Luteolin in Overcoming Alzheimer’s Disease
Fahad Ali, Yasir Hasan Siddique
CNS & Neurological Disorders - Drug Targets (2019) Vol. 18, Iss. 5, pp. 352-365
Closed Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Scopolamine, a Toxin-Induced Experimental Model, Used for Research in Alzheimer’s Disease
Win Ning Chen, Keng Yoon Yeong
CNS & Neurological Disorders - Drug Targets (2020) Vol. 19, Iss. 2, pp. 85-93
Closed Access | Times Cited: 88
Luteolin, inflammation and cancer: Special emphasis on gut microbiota
Laura Franza, Valentina Carusi, Eleonora Nucera, et al.
BioFactors (2021) Vol. 47, Iss. 2, pp. 181-189
Closed Access | Times Cited: 75
Novel Luteolin-Loaded Chitosan Decorated Nanoparticles for Brain-Targeting Delivery in a Sporadic Alzheimer’s Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways
Haidy Abbas, Nesrine S. El Sayed, Nancy Abdel Hamid Abou Youssef, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 1003-1003
Open Access | Times Cited: 51
Comprehensive overview of Nrf2-related epigenetic regulations involved in ischemia-reperfusion injury
Jun Zhang, Wanqian Pan, Yue Zhang, et al.
Theranostics (2022) Vol. 12, Iss. 15, pp. 6626-6645
Open Access | Times Cited: 45
Dietary flavonoids and human top-ranked diseases: The perspective of in vivo bioactivity and bioavailability
Di Zhou, Zisong Bai, Tingting Guo, et al.
Trends in Food Science & Technology (2022) Vol. 120, pp. 374-386
Closed Access | Times Cited: 38
Luteolin, a flavone ingredient: Anticancer mechanisms, combined medication strategy, pharmacokinetics, clinical trials, and pharmaceutical researches
Mingyi Shi, Zixian Chen, Hui Gong, et al.
Phytotherapy Research (2023) Vol. 38, Iss. 2, pp. 880-911
Closed Access | Times Cited: 25
Application of Luteolin in Neoplasms and Nonneoplastic Diseases
Katarzyna Rakoczy, Justyna Kaczor, Adam Sołtyk, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15995-15995
Open Access | Times Cited: 22
Protective effect of flavonoids on oxidative stress injury in Alzheimer’s disease
Kaixuan Wang, Xinmei Chen
Natural Product Research (2024), pp. 1-28
Closed Access | Times Cited: 9
A Brain-Targeted Approach to Ameliorate Memory Disorders in a Sporadic Alzheimer’s Disease Mouse Model via Intranasal Luteolin-Loaded Nanobilosomes
Manal A Elsheikh, Yasmin A. El-Feky, Majid Mohammad Al-Sawahli, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 576-576
Open Access | Times Cited: 36
Beneficial effects of apigenin on the transgenic Drosophila model of Alzheimer's disease
Yasir Hasan Siddique, Rahul, Gulshan Ara, et al.
Chemico-Biological Interactions (2022) Vol. 366, pp. 110120-110120
Closed Access | Times Cited: 28
Luteolin Mitigates D-Galactose-Induced Brain Ageing in Rats: SIRT1-Mediated Neuroprotection
Reham L. Younis, Rehab M. El‐Gohary, Asmaa A. Ghalwash, et al.
Neurochemical Research (2024) Vol. 49, Iss. 10, pp. 2803-2820
Open Access | Times Cited: 6
Luteolin Attenuates IL-1β-Induced THP-1 Adhesion to ARPE-19 Cells via Suppression of NF-κB and MAPK Pathways
Wen‐Chung Huang, Chian‐Jiun Liou, Szu‐Chuan Shen, et al.
Mediators of Inflammation (2020) Vol. 2020, pp. 1-15
Open Access | Times Cited: 36
Neuroinflammation in Alzheimer's disease and beneficial action of luteolin
Alejandro Delgado, Christos Cholevas, Theoharis C. Theoharides
BioFactors (2021) Vol. 47, Iss. 2, pp. 207-217
Closed Access | Times Cited: 29
Restoring the oxidative balance in age-related diseases – An approach in glaucoma
Paolin Rocio Cáceres‐Vélez, Flora Hui, Julie Hercus, et al.
Ageing Research Reviews (2022) Vol. 75, pp. 101572-101572
Open Access | Times Cited: 22
Luteolin binds Src, promotes STAT3 protein ubiquitination and exerts anti-melanoma effects in cell and mouse models
Ting Li, Xiu‐Qiong Fu, Bin Liu, et al.
Biochemical Pharmacology (2022) Vol. 200, pp. 115044-115044
Closed Access | Times Cited: 19
The Emerging Role of Flavonoids in Autism Spectrum Disorder: A Systematic Review
Rosa Savino, Alessandro Medoro, Sawan Alì, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3520-3520
Open Access | Times Cited: 12
The potential anti-Alzheimer's activity of Oxalis corniculata Linn. Methanolic extract in experimental rats: Role of APOE4/LRP1, TLR4/NF-κβ/NLRP3, Wnt 3/β-catenin/GSK-3β, autophagy and apoptotic cues
Karema Abu‐Elfotuh, Ahmed M. Hamdan, Shaza A. Mohamed, et al.
Journal of Ethnopharmacology (2024) Vol. 324, pp. 117731-117731
Open Access | Times Cited: 4
Luteolin alleviates diabetic cardiac injury related to inhibiting SHP2/STAT3 pathway
Jie Pan, M Chen, Chunyan Jiang, et al.
European Journal of Pharmacology (2025) Vol. 989, pp. 177259-177259
Closed Access
Natural products against tau hyperphosphorylation‐induced aggregates: Potential therapies for Alzheimer's disease
Gustavo Basurto‐Islas, Mario Dı́az, Lizeth M. Zavala Ocampo, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 1
Open Access
Luteolin: exploring its therapeutic potential and molecular mechanisms in pulmonary diseases
Jialian Lv, Xinyue Song, Zixin Luo, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Pre-clinical evidence for mitochondria as a therapeutic target for luteolin: a mechanistic view
Marcos Roberto de Oliveira
Chemico-Biological Interactions (2025), pp. 111492-111492
Closed Access
Identification and Exploration of Immunity‐Related Genes and Natural Products for Alzheimer's Disease Based on Bioinformatics, Molecular Docking, and Molecular Dynamics
Pengpeng Liang, Chang Ye Yale Wang, J Liu, et al.
Immunity Inflammation and Disease (2025) Vol. 13, Iss. 4
Open Access
Research Progress of Genomics Applications in Secondary Metabolites of Medicinal Plants: A Case Study in Safflower
Zhihua Wu, Yan Na Hu, Rui Hao, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3867-3867
Open Access
The neuroprotective effect and action mechanism of polyphenols in diabetes mellitus-related cognitive dysfunction
Shenshen Zhang, Ran Xue, Ruizhe Hu
European Journal of Nutrition (2019) Vol. 59, Iss. 4, pp. 1295-1311
Closed Access | Times Cited: 33
Scutellaria barbata D. Don Inhibits the Main Proteases (Mpro and TMPRSS2) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Sheng‐Teng Huang, Yeh Chen, Wei‐Chao Chang, et al.
Viruses (2021) Vol. 13, Iss. 5, pp. 826-826
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top